Intracardiac Echocardiography Guided Watchman Device Implant

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Cleveland Clinic

About this trial

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

Eligibility criteria

Qualifiers

All patients who meet guideline established criteria for commercially available Watchman device implant and not enrolled in an active clinical trial

Disqualifiers

Patients in whom a procedural TEE cannot be performed and an ICE only implant is needed.

Patients receiving a concomitant ablation procedure

Patients with prior incomplete surgical or percutaneous left atrial appendage ligation/exclusion procedures

Patients in whom the delivery of trans-septal equipment is anticipated to be difficult (e.g. patent foramen ovale (PFO) or atrial septal defect (ASD) closure devices in place).

Trial design

Treatments tested in this trial

  • Intracardiac Echocardiography (ICE)

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators